No black box warning on record for Cabenuva
As of the latest FDA labeling reviewed, Cabenuva (CABOTEGRAVIR AND RILPIVIRINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cabenuva medicine page for the complete safety profile.